These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 19027794

  • 1. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
    Fukushima A, Sumi T, Ishida W, Ojima A, Kajisako M, Koyanagi A, Koyama N, Yagita H.
    Immunol Lett; 2008 Dec 22; 121(2):140-7. PubMed ID: 19027794
    [Abstract] [Full Text] [Related]

  • 2. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Yagita H, Ueno H.
    Invest Ophthalmol Vis Sci; 2006 Feb 22; 47(2):657-63. PubMed ID: 16431965
    [Abstract] [Full Text] [Related]

  • 3. CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.
    Sumi T, Ishida W, Ojima A, Kajisako M, Sakanishi T, Yagita H, Fukushima A.
    Immunol Lett; 2008 Aug 15; 119(1-2):91-6. PubMed ID: 18579220
    [Abstract] [Full Text] [Related]

  • 4. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
    Fukushima A, Ishida W, Ojima A, Kajisako M, Sumi T, Yamada J, Tsuru E, Miyazaki J, Tominaga A, Yagita H.
    Int Arch Allergy Immunol; 2010 Aug 15; 151(2):129-36. PubMed ID: 19752566
    [Abstract] [Full Text] [Related]

  • 5. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A, Sumi T, Ishida W, Yamada J, Iwakura Y, Ueno H.
    Int Arch Allergy Immunol; 2008 Aug 15; 147(3):206-12. PubMed ID: 18594150
    [Abstract] [Full Text] [Related]

  • 6. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Okumura K, Akiba H, Yagita H, Ueno H.
    Int Arch Allergy Immunol; 2008 Aug 15; 146(1):36-43. PubMed ID: 18087160
    [Abstract] [Full Text] [Related]

  • 7. Role of VLA-4 in the development of allergic conjunctivitis in mice.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ueno H.
    Mol Vis; 2006 Apr 07; 12():310-7. PubMed ID: 16617298
    [Abstract] [Full Text] [Related]

  • 8. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Ozaki A, Ueno H.
    Immunol Lett; 2005 Sep 15; 100(2):189-94. PubMed ID: 15919119
    [Abstract] [Full Text] [Related]

  • 9. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Ueno H.
    Int Arch Allergy Immunol; 2007 Sep 15; 144(1):79-84. PubMed ID: 17505142
    [Abstract] [Full Text] [Related]

  • 10. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
    Sumi T, Ishida W, Okumura K, Yagita H, Fukushima A.
    Br J Ophthalmol; 2009 Jan 15; 93(1):110-5. PubMed ID: 18782797
    [Abstract] [Full Text] [Related]

  • 11. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T, Fukushima A, Nishino K, Fukuda K, Kumagai N, Nishida T, Ueno H.
    Cell Biol Int; 2009 Apr 15; 33(4):534-41. PubMed ID: 19230848
    [Abstract] [Full Text] [Related]

  • 12. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.
    Fukushima A, Yamaguchi T, Azuma M, Yagita H, Ueno H.
    Br J Ophthalmol; 2006 Aug 15; 90(8):1040-5. PubMed ID: 16613922
    [Abstract] [Full Text] [Related]

  • 13. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
    Sumi T, Ishida W, Mittler RS, Yagita H, Taguchi O, Fukushima A.
    Int Arch Allergy Immunol; 2009 Aug 15; 148(4):305-10. PubMed ID: 19001790
    [Abstract] [Full Text] [Related]

  • 14. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis.
    Ishida W, Tsuru E, Tominaga A, Miyazaki JI, Higuchi T, Sakamoto S, Fukushima A.
    Br J Ophthalmol; 2009 Dec 15; 93(12):1680-5. PubMed ID: 19692377
    [Abstract] [Full Text] [Related]

  • 15. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.
    Fukushima A, Sumi T, Fukuda K, Kumagai N, Nishida T, Yagita H, Ueno H.
    Br J Ophthalmol; 2006 Dec 15; 90(12):1535-41. PubMed ID: 16914468
    [Abstract] [Full Text] [Related]

  • 16. CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis.
    Fukushima A, Yamaguchi T, Fukuda K, Sumi T, Kumagai N, Nishida T, Imai S, Ueno H.
    Microbiol Immunol; 2006 Dec 15; 50(9):719-28. PubMed ID: 16985294
    [Abstract] [Full Text] [Related]

  • 17. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Taniguchi T, Liu FT, Ueno H.
    Exp Eye Res; 2006 Feb 15; 82(2):210-8. PubMed ID: 16102751
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A, Yamaguchi T, Ishida W, Fukata K, Liu FT, Ueno H.
    Clin Exp Ophthalmol; 2006 Feb 15; 34(4):347-53. PubMed ID: 16764655
    [Abstract] [Full Text] [Related]

  • 19. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
    Fukushima A, Yamaguchi T, Ozaki A, Taniguchi T, Udaka K, Ueno H.
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct 15; 243(10):1043-9. PubMed ID: 15838661
    [Abstract] [Full Text] [Related]

  • 20. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
    Fukushima A, Sumi T, Fukuda K, Yamaguchi T, Kumagai N, Nishida T, Ueno H.
    Immunol Lett; 2006 Sep 15; 107(1):32-40. PubMed ID: 16930723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.